Sveriges mest populära poddar
Blood Podcast
Blood Podcast

Season 1, Episode 51

17 min•17 december 2020

Om avsnittet

In this week’s episode, we will learn more about T-cells from SARS-CoV-2-infected individuals, review a study that describes the rapid clinical and histologic response to anti-PD1 first-line therapy in early-stage, unfavorable Hodgkin lymphoma, and discuss a meta-analysis and systematic review of outcomes of patients with hematologic malignancies and Covid-19.

Fler avsnitt

Visa alla avsnitt av Blood Podcast

Designing Durable Remissions in Relapsed AML and Follicular Lymphoma

16 min

Dose Makes the Cure: Venetoclax in Ph- ALL

14 min

Exploiting Vulnerabilities in High‑Risk MM and Mapping the Red Cell Interactome

30 min

MYB driven ALL and Venetoclax-Azacitidine damage to Bone Marrow

25 min

Predictive Markers of Glofitamab Resistance in R/R B-NHL

16 min

Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

26 min

Balancing Infection and Thrombosis: Bispecific Antibodies and the Many Roles of HRG

15 min

Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies

33 min

HLH-like toxicities after CAR-T and Structure-Function Relationships of FNAIT

17 min

FLT3-ITD microclones in AML and Results from the RESET-PV trial

14 min

Blood Podcast med American Society of Hematology finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.